These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9159558)

  • 1. Pharmacoeconomics: evaluating the evaluators.
    Haycox A; Walley T
    Br J Clin Pharmacol; 1997 May; 43(5):451-6. PubMed ID: 9159558
    [No Abstract]   [Full Text] [Related]  

  • 2. A proposal for Italian guidelines in pharmacoeconomics The Mario Negri Institute Centre for Health Economics.
    Garattini L; Grilli R; Scopelliti D; Mantovani L
    Pharmacoeconomics; 1995 Jan; 7(1):1-6. PubMed ID: 10155289
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of pharmacoeconomics in prescribing research. Part 1: costs--moving beyond the acquisition price for drugs.
    Robertson J; Lang D; Hill S
    J Clin Pharm Ther; 2003 Feb; 28(1):73-9. PubMed ID: 12605622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental cost-effectiveness ratio and net monetary benefit: Current use in pharmacoeconomics and future perspectives.
    Trippoli S
    Eur J Intern Med; 2017 Sep; 43():e36. PubMed ID: 28552463
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of pharmacoeconomics in prescribing research. Part 3: Cost-effectiveness analysis--a technique for decision-making at the margin.
    Lopert R; Lang DL; Hill SR
    J Clin Pharm Ther; 2003 Jun; 28(3):243-9. PubMed ID: 12795784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research on hospital drug cost control based on the perspective of pharmaceutical economy.
    Xiu Y; Jia L; Chen J; Cui W
    Pak J Pharm Sci; 2017 May; 30(3(Special)):1057-1062. PubMed ID: 28671081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacoeconomics. A new concept of an old practice].
    Palma-Aguirre JA
    Gac Med Mex; 1998; 134(5):621-4. PubMed ID: 9842147
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacoeconomics. Potent drugs, diseases are costly].
    Flaten O
    Tidsskr Nor Laegeforen; 1994 Apr; 114(11):1345-6. PubMed ID: 8079219
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacoeconomics of asthma].
    Jahnz-Rózyk K; Targowski T
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():48-9. PubMed ID: 15524016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of pharmacoeconomics. Introduction].
    Carrera-Hueso FJ
    Farm Hosp; 2011 May; 35 Suppl 2():1-2. PubMed ID: 22553826
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacoeconomics in Ireland. Concepts and terminology.
    Barry M; Feely J
    Ir J Med Sci; 2000; 169(1):63-4. PubMed ID: 10846864
    [No Abstract]   [Full Text] [Related]  

  • 12. The power of pharmacoeconomics.
    Healthc Exec; 2000; 15(1):44-5. PubMed ID: 11067028
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacoeconomics comes of age?
    Walley T; Breckenridge A
    Clin Pharmacol Ther; 2008 Aug; 84(2):279-80. PubMed ID: 18563057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoeconomics in the era of individualized medicine.
    Waldman SA; Terzic A
    Clin Pharmacol Ther; 2008 Aug; 84(2):179-82. PubMed ID: 18679176
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacoeconomics is coming of age.
    Pizzi L; Singh V
    Clin Pharmacol Ther; 2008 Aug; 84(2):188-90. PubMed ID: 18679179
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacoeconomics.
    Ahuja J; Gupta M; Gupta AK; Kohli K
    Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observational studies and "real world" anesthesia pharmacoeconomics.
    Miller DR; Tierney M
    Can J Anaesth; 2002 Apr; 49(4):329-34. PubMed ID: 11927469
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug cost management in pharmacy management based on pharmacoeconomics: Antimicrobial treatment cases.
    Liu S; He L; Sun L; Wang Y
    Pak J Pharm Sci; 2017 May; 30(3(Special)):1069-1073. PubMed ID: 28671083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations in the pharmacoeconomics of glaucoma.
    Hirsch JD
    Manag Care; 2002 Nov; 11(11 Suppl):32-7. PubMed ID: 15357537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacoeconomics of spiralling cancer drug costs - is there a viable solution?
    Alifrangis C; Krell J; Stebbing J
    Eur J Cancer; 2011 Jun; 47(9):1285-6. PubMed ID: 21550231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.